This Penny Stock To Consider Bonus Issue And Up to 100% Dividend For FY25

Murae Organisor Limited was recently the talk of the town, rising to 5% upper circuit at Rs 1.95 in Tuesday's trading session, which was a surge from the preceding day's close of Rs 1.86. This is the stock's eighth consecutive upper-circuit surge. Murae Organisor has raised significant traction in recent weeks. The stock breached its 52-week high of Rs 2.73 and low of Rs 1.04, the stock earning 87.5%, signifying an opportunistic bullish attitude from investors.

Murae Organisor surge comes just days ahead when the company has a Board of Directors meeting scheduled for June 13, 2025 which has many critical proposals lined up. Out of the many discussed, the Murae Organisor's Board agenda shall include the declaration of the dividend up to 100% for the fiscal year ended 31st March 2025, subject to shareholders' consent. Murae Organisor's Board also plans to discuss a bonus issue proposal, other relevant matters at the chair's discretion.

In a bid to enhance liquidity further and make the stock more accessible to retail investors, the company has approved a 1:2 stock split, which will be effective starting June 11th, 2025. This will turn each equity share of Rs 2 face value into two shares of Rs 1 each. While the total paid-up capital will remain the same at Rs 1,85,89,64,310, the equity shares will increase from Rs 1,00,00,000 to Rs 2,00,00,000, thus broadening the market participation.

Murae Organisor's financial performance has been far above average. For the quarter ending March 30, 2025 (Q4FY25), the company posted net sales of Rs 515.53 crore, which was an impressive 59,845% increase year-on-year, with a net profit of Rs 2.85 crore, which was a 144% increase. For the entire financial year, sales on a net basis soared by 33,554% to Rs 854.82 crore. Net profit increased by 14,940% to Rs 7.52 crore, however, showing a stark shift in business performance. The company's market cap is valued at 181.25 crore as of the last close mark, while 100% of the shares are owned by public investors. Currently, the stock is trading at 0.90 times its book value.

Established in 2012, Murae Organisor has been engaged in the pharmaceutical industry for more than a decade now, with a focus on marketing and trading of over 120 branded products which include HYGNEX+, Erolon and Calcybar. In addition to outsourcing manufacturing to third-party facilities, Murae Organisor also trades in active pharmaceutical ingredients.

Covering a wide spectrum of therapeutic areas, Murae Organisor's product portfolio includes antibiotics, antimalarials, antiallergic drugs, dermatology, neurology, gastrointestinal care, and nutritional supplements. Proactively expanding its international footprint, the company exports to more than 15 countries, including North America, CIS, Latin America, Africa, and Southeast Asia, and is in the process of registering over 60 international products.